GLP-1 drugs such as Ozempic and Wegovy are everywhere, but most people dont know what they do or how they work. GLP-1 drugs were originally prescribed to people with type 2 diabetes or obesity, but ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

Aaliyah Pasols is an award-winning journalist and editor who primarily covers lifestyle, culture, and entertainment. Originally from South Florida, she studied at Florida International University, ...

Technology Networks spoke with Waters’ Dr. Matthew Lauber about the analytical challenges posed by GLP-1s and other complex biopharmaceuticals, why impurity separation matters, and how bioseparation ...

GLP-1 drugs have transformed the conversation around obesity and diabetes. Medicines such as semaglutide and liraglutide are widely known for helping people lo ...

On July 1, 2026, Medicare launched the GLP-1 Bridge Program for Foundayo (orforglipron), Wegovy (semaglutide), and Zepbound (tirzepatide). For the next 18 months, the program flattens the price of ...

A Journal of Clinical Investigation Viewpoint highlights growing evidence that GLP-1 receptor agonists, particularly ...

Please provide your email address to receive an email when new articles are posted on . Sleep apnea incidence in obesity and/or type 2 diabetes was reduced with vs. without GLP-1/dual agonist therapy ...